Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue

American Journal of Pathology

Volumn 185, Issue 7, 2015, Pages 1834-1845

  Luo, Jian Hua ^a   Liu, Silvia ^b   Zuo, Ze Hua ^a   Chen, Rui ^b   Tseng, George C ^b   Yu, Yan P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALG5 PIGU FUSION PROTEIN; HYBRID PROTEIN; MAN2A1 FER FUSION PROTEIN; MESSENGER RNA; RNA; TMPRSS2 ERG FUSION PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CHIMERA; CHROMOSOME REARRANGEMENT; CLINICAL CLASSIFICATION; CODON; EXON; FUSION GENE; GENE SEQUENCE; GENE STRUCTURE; GENETIC RECOMBINATION; HOUSEKEEPING GENE; HUMAN; MALIGNANT TRANSFORMATION; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROSTATE CANCER; PROSTATE TISSUE; RIBOSOME; RNA RECOMBINATION; RNA SEQUENCE; TRANSCRIPTOMICS; CLASSIFICATION; GENE FUSION; GENETICS; MALE; PHYSIOLOGY; PROSTATE TUMOR; SEQUENCE ANALYSIS;

GENE FUSION; HUMANS; MALE; ONCOGENE FUSION; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA;

EID: 84931468248     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.03.008     Document Type: Review

References (100)

1. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
2. J.H. Luo, Y.P. Yu, K. Cieply, F. Lin, P. Deflavia, R. Dhir, S. Finkelstein, G. Michalopoulos, and M. Becich Gene expression analysis of prostate cancers Mol Carcinog 33 2002 25 35
3. J.H. Luo, and Y.P. Yu Genetic factors underlying prostate cancer Expert Rev Mol Med 5 2003 1 26
4. Y.P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, G. Michalopoulos, M. Becich, and J.H. Luo Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J Clin Oncol 22 2004 2790 2799
5. Y.P. Yu, S. Paranjpe, J. Nelson, S. Finkelstein, B. Ren, D. Kokkinakis, G. Michalopoulos, and J.H. Luo High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array Carcinogenesis 26 2005 471 479
6. Y.P. Yu, C. Song, G. Tseng, B.G. Ren, W. Laframboise, G. Michalopoulos, J. Nelson, and J.H. Luo Genome abnormalities precede prostate cancer and predict clinical relapse Am J Pathol 180 2012 2240 2248
7. J.H. Luo, Y. Ding, R. Chen, G. Michalopoulos, J. Nelson, G. Tseng, and Y.P. Yu Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer Am J Pathol 182 2013 2028 2036
8. Y.P. Yu, Y. Ding, R. Chen, S.G. Liao, B.G. Ren, A. Michalopoulos, G. Michalopoulos, J. Nelson, G.C. Tseng, and J.H. Luo Whole-genome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer Am J Pathol 183 2013 1960 1970
9. J.H. Luo Gene expression alterations in human prostate cancer Drugs Today (Barc) 38 2002 713 719
10. B. Ren, Y.P. Yu, G.C. Tseng, C. Wu, K. Chen, U.N. Rao, J. Nelson, G.K. Michalopoulos, and J.H. Luo Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma J Natl Cancer Inst 99 2007 868 880
11. F. Lin, Y.P. Yu, J. Woods, K. Cieply, B. Gooding, P. Finkelstein, R. Dhir, D. Krill, M.J. Becich, G. Michalopoulos, S. Finkelstein, and J.H. Luo Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers Am J Pathol 159 2001 1603 1612
12. B.S. Taylor, N. Schultz, H. Hieronymus, A. Gopalan, Y. Xiao, B.S. Carver, V.K. Arora, P. Kaushik, E. Cerami, B. Reva, Y. Antipin, N. Mitsiades, T. Landers, I. Dolgalev, J.E. Major, M. Wilson, N.D. Socci, A.E. Lash, A. Heguy, J.A. Eastham, H.I. Scher, V.E. Reuter, P.T. Scardino, C. Sander, C.L. Sawyers, and W.L. Gerald Integrative genomic profiling of human prostate cancer Cancer Cell 18 2010 11 22
13. S. Hughes, M. Yoshimoto, B. Beheshti, R.S. Houlston, J.A. Squire, and A. Evans The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression BMC Genomics 7 2006 65
14. S.C. Baca, D. Prandi, M.S. Lawrence, J.M. Mosquera, A. Romanel, and Y. Drier Punctuated evolution of prostate cancer genomes Cell 153 2013 666 677
15. Y.P. Yu, Y. Ding, Z. Chen, S. Liu, A. Michalopoulos, R. Chen, Z.G. Gulzar, B. Yang, K.M. Cieply, A. Luvison, B.G. Ren, J.D. Brooks, D. Jarrard, J.B. Nelson, G.K. Michalopoulos, G.C. Tseng, and J.H. Luo Novel fusion transcripts associate with progressive prostate cancer Am J Pathol 184 2014 2840 2849
16. K.H. Lee, G.J. Song, I.S. Kang, S.W. Kim, J.S. Paick, C.H. Chung, and K. Rhee Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome Reprod Fertil Dev 15 2003 129 133
17. S. Ren, Z. Peng, J.H. Mao, Y. Yu, C. Yin, X. Gao, Z. Cui, J. Zhang, K. Yi, W. Xu, C. Chen, F. Wang, X. Guo, J. Lu, J. Yang, M. Wei, Z. Tian, Y. Guan, L. Tang, C. Xu, L. Wang, X. Gao, W. Tian, J. Wang, H. Yang, J. Wang, and Y. Sun RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings Cell Res 22 2012 806 821
18. J.A. West, C.P. Davis, H. Sunwoo, M.D. Simon, R.I. Sadreyev, P.I. Wang, M.Y. Tolstorukov, and R.E. Kingston The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites Mol Cell 55 2014 791 802
19. P. Ji, S. Diederichs, W. Wang, S. Boing, R. Metzger, P.M. Schneider, N. Tidow, B. Brandt, H. Buerger, E. Bulk, M. Thomas, W.E. Berdel, H. Serve, and C. Muller-Tidow MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer Oncogene 22 2003 8031 8041
20. Y. Han, Y. Liu, L. Nie, Y. Gui, and Z. Cai Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder Urology 81 2013 209.e1 209.e7
21. Y. Jiang, Y. Li, S. Fang, B. Jiang, C. Qin, P. Xie, G. Zhou, and G. Li The role of MALAT1 correlates with HPV in cervical cancer Oncol Lett 7 2014 2135 2141
22. G. Li, H. Zhang, X. Wan, X. Yang, C. Zhu, A. Wang, L. He, R. Miao, S. Chen, and H. Zhao Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma Biomed Res Int 2014 2014 780521
23. T. Gutschner, M. Hammerle, M. Eissmann, J. Hsu, Y. Kim, G. Hung, A. Revenko, G. Arun, M. Stentrup, M. Gross, M. Zornig, A.R. MacLeod, D.L. Spector, and S. Diederichs The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells Cancer Res 73 2013 1180 1189
24. H.M. Zhang, F.Q. Yang, S.J. Chen, J. Che, and J.H. Zheng Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma Tumour Biol 36 2015 2947 2955
25. J.H. Luo, B. Ren, S. Keryanov, G.C. Tseng, U.N. Rao, S.P. Monga, S. Strom, A.J. Demetris, M. Nalesnik, Y.P. Yu, S. Ranganathan, and G.K. Michalopoulos Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas Hepatology 44 2006 1012 1024
26. C. Xu, M. Yang, J. Tian, X. Wang, and Z. Li MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis Int J Oncol 39 2011 169 175
27. V. Tripathi, J.D. Ellis, Z. Shen, D.Y. Song, Q. Pan, A.T. Watt, S.M. Freier, C.F. Bennett, A. Sharma, P.A. Bubulya, B.J. Blencowe, S.G. Prasanth, and K.V. Prasanth The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation Mol Cell 39 2010 925 938
28. V. Tripathi, Z. Shen, A. Chakraborty, S. Giri, S.M. Freier, X. Wu, Y. Zhang, M. Gorospe, S.G. Prasanth, A. Lal, and K.V. Prasanth Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB PLoS Genet 9 2013 e1003368
29. J.A. Brown, M.L. Valenstein, T.A. Yario, K.T. Tycowski, and J.A. Steitz Formation of triple-helical structures by the 3'-end sequences of MALAT1 and MENbeta noncoding RNAs Proc Natl Acad Sci U S A 109 2012 19202 19207
30. F. Yang, F. Yi, X. Han, Q. Du, and Z. Liang MALAT-1 interacts with hnRNP C in cell cycle regulation FEBS Lett 587 2013 3175 3181
31. X.S. Wu, X.A. Wang, W.G. Wu, Y.P. Hu, M.L. Li, Q. Ding, H. Weng, Y.J. Shu, T.Y. Liu, L. Jiang, Y. Cao, R.F. Bao, J.S. Mu, Z.J. Tan, F. Tao, and Y.B. Liu MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway Cancer Biol Ther 15 2014 806 814
32. K.M. Michalik, X. You, Y. Manavski, A. Doddaballapur, M. Zornig, T. Braun, D. John, Y. Ponomareva, W. Chen, S. Uchida, R.A. Boon, and S. Dimmeler Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth Circ Res 114 2014 1389 1397
33. Q. Ji, X. Liu, X. Fu, L. Zhang, H. Sui, L. Zhou, J. Sun, J. Cai, J. Qin, J. Ren, and Q. Li Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway PLoS One 8 2013 e78700
34. J. Wang, L. Su, X. Chen, P. Li, Q. Cai, B. Yu, B. Liu, W. Wu, and Z. Zhu MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF Biomed Pharmacother 68 2014 557 564
35. Y. Dong, G. Liang, B. Yuan, C. Yang, R. Gao, and X. Zhou MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway Tumour Biol 36 2015 1477 1486
36. J.E. Wilusz, C.K. JnBaptiste, L.Y. Lu, C.D. Kuhn, L. Joshua-Tor, and P.A. Sharp A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails Genes Dev 26 2012 2392 2407
37. J.P. Clark, and C.S. Cooper ETS gene fusions in prostate cancer Nat Rev Urol 6 2009 429 439
38. F.Y. Feng, J.C. Brenner, M. Hussain, and A.M. Chinnaiyan Molecular pathways: targeting ETS gene fusions in cancer Clin Cancer Res 20 2014 4442 4448
39. M.F. Nunn, P.H. Seeburg, C. Moscovici, and P.H. Duesberg Tripartite structure of the avian erythroblastosis virus E26 transforming gene Nature 306 1983 391 395
40. S.A. Tomlins, D.R. Rhodes, S. Perner, S.M. Dhanasekaran, R. Mehra, X.W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, C. Lee, J.E. Montie, R.B. Shah, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648
41. K. Iljin, M. Wolf, H. Edgren, S. Gupta, S. Kilpinen, R.I. Skotheim, M. Peltola, F. Smit, G. Verhaegh, J. Schalken, M. Nees, and O. Kallioniemi TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming Cancer Res 66 2006 10242 10246
42. G. Attard, J. Clark, L. Ambroisine, I.G. Mills, G. Fisher, P. Flohr, A. Reid, S. Edwards, G. Kovacs, D. Berney, C. Foster, C.E. Massie, A. Fletcher, J.S. De Bono, P. Scardino, J. Cuzick, C.S. Cooper Transatlantic Prostate Group Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer Br J Cancer 99 2008 314 320
43. B. Han, R. Mehra, S.M. Dhanasekaran, J. Yu, A. Menon, R.J. Lonigro, X. Wang, Y. Gong, L. Wang, S. Shankar, B. Laxman, R.B. Shah, S. Varambally, N. Palanisamy, S.A. Tomlins, C. Kumar-Sinha, and A.M. Chinnaiyan A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer Cancer Res 68 2008 7629 7637
44. S.A. Tomlins, R. Mehra, D.R. Rhodes, L.R. Smith, D. Roulston, B.E. Helgeson, X. Cao, J.T. Wei, M.A. Rubin, R.B. Shah, and A.M. Chinnaiyan TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer Cancer Res 66 2006 3396 3400
45. K.G. Hermans, A.A. Bressers, H.A. van der Korput, N.F. Dits, G. Jenster, and J. Trapman Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer Cancer Res 68 2008 3094 3098
46. K.G. Hermans, H.A. van der Korput, R. van Marion, D.J. van de Wijngaart, A. Ziel-van der Made, N.F. Dits, J.L. Boormans, T.H. van der Kwast, H. van Dekken, C.H. Bangma, H. Korsten, R. Kraaij, G. Jenster, and J. Trapman Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer Cancer Res 68 2008 7541 7549
47. S. Jhavar, A. Reid, J. Clark, Z. Kote-Jarai, T. Christmas, A. Thompson, C. Woodhouse, C. Ogden, C. Fisher, C. Corbishley, J. De-Bono, R. Eeles, D. Brewer, and C. Cooper Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays J Mol Diagn 10 2008 50 57
48. A.M. Udager, Y. Shi, S.A. Tomlins, A. Alva, J. Siddiqui, X. Cao, K.J. Pienta, H. Jiang, A.M. Chinnaiyan, and R. Mehra Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer Prostate 74 2014 1199 1208
49. S.A. Tomlins, B. Laxman, S.M. Dhanasekaran, B.E. Helgeson, X. Cao, D.S. Morris, A. Menon, X. Jing, Q. Cao, B. Han, J. Yu, L. Wang, J.E. Montie, M.A. Rubin, K.J. Pienta, D. Roulston, R.B. Shah, S. Varambally, R. Mehra, and A.M. Chinnaiyan Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer Nature 448 2007 595 599
50. B.S. Carver, J. Tran, A. Gopalan, Z. Chen, S. Shaikh, A. Carracedo, A. Alimonti, C. Nardella, S. Varmeh, P.T. Scardino, C. Cordon-Cardo, W. Gerald, and P.P. Pandolfi Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate Nat Genet 41 2009 619 624
51. O. Klezovitch, M. Risk, I. Coleman, J.M. Lucas, M. Null, L.D. True, P.S. Nelson, and V. Vasioukhin A causal role for ERG in neoplastic transformation of prostate epithelium Proc Natl Acad Sci U S A 105 2008 2105 2110
52. J.C. King, J. Xu, J. Wongvipat, H. Hieronymus, B.S. Carver, D.H. Leung, B.S. Taylor, C. Sander, R.D. Cardiff, S.S. Couto, W.L. Gerald, and C.L. Sawyers Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis Nat Genet 41 2009 524 526
53. Y. Zong, L. Xin, A.S. Goldstein, D.A. Lawson, M.A. Teitell, and O.N. Witte ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells Proc Natl Acad Sci U S A 106 2009 12465 12470
54. B.S. Carver, J. Tran, Z. Chen, A. Carracedo-Perez, A. Alimonti, C. Nardella, A. Gopalan, P.T. Scardino, C. Cordon-Cardo, W. Gerald, and P.P. Pandolfi ETS rearrangements and prostate cancer initiation Nature 457 2009 E1 discussion E2-3
55. N. Cerveira, F.R. Ribeiro, A. Peixoto, V. Costa, R. Henrique, C. Jeronimo, and M.R. Teixeira TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions Neoplasia 8 2006 826 832
56. S. Perner, J.M. Mosquera, F. Demichelis, M.D. Hofer, P.L. Paris, J. Simko, C. Collins, T.A. Bismar, A.M. Chinnaiyan, A.M. De Marzo, and M.A. Rubin TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion Am J Surg Pathol 31 2007 882 888
57. J.M. Mosquera, S. Perner, E.M. Genega, M. Sanda, M.D. Hofer, K.D. Mertz, P.L. Paris, J. Simko, T.A. Bismar, G. Ayala, R.B. Shah, M. Loda, and M.A. Rubin Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications Clin Cancer Res 14 2008 3380 3385
58. G. Petrovics, A. Liu, S. Shaheduzzaman, B. Furusato, C. Sun, Y. Chen, M. Nau, L. Ravindranath, Y. Chen, A. Dobi, V. Srikantan, I.A. Sesterhenn, D.G. McLeod, M. Vahey, J.W. Moul, and S. Srivastava Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome Oncogene 24 2005 3847 3852
59. M. Winnes, E. Lissbrant, J.E. Damber, and G. Stenman Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer Oncol Rep 17 2007 1033 1036
60. O.R. Saramaki, A.E. Harjula, P.M. Martikainen, R.L. Vessella, T.L. Tammela, and T. Visakorpi TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis Clin Cancer Res 14 2008 3395 3400
61. J. Lapointe, C. Li, C.P. Giacomini, K. Salari, S. Huang, P. Wang, M. Ferrari, T. Hernandez-Boussard, J.D. Brooks, and J.R. Pollack Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis Cancer Res 67 2007 8504 8510
62. J.J. Tu, S. Rohan, J. Kao, N. Kitabayashi, S. Mathew, and Y.T. Chen Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues Mod Pathol 20 2007 921 928
63. S. Perner, F. Demichelis, R. Beroukhim, F.H. Schmidt, J.M. Mosquera, S. Setlur, J. Tchinda, S.A. Tomlins, M.D. Hofer, K.G. Pienta, R. Kuefer, R. Vessella, X.W. Sun, M. Meyerson, C. Lee, W.R. Sellers, A.M. Chinnaiyan, and M.A. Rubin TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer Cancer Res 66 2006 8337 8341
64. A. Gopalan, M.A. Leversha, J.M. Satagopan, Q. Zhou, H.A. Al-Ahmadie, S.W. Fine, J.A. Eastham, P.T. Scardino, H.I. Scher, S.K. Tickoo, V.E. Reuter, and W.L. Gerald TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy Cancer Res 69 2009 1400 1406
65. J. Wang, Y. Cai, C. Ren, and M. Ittmann Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer Cancer Res 66 2006 8347 8351
66. R.K. Nam, L. Sugar, W. Yang, S. Srivastava, L.H. Klotz, L.Y. Yang, A. Stanimirovic, E. Encioiu, M. Neill, D.A. Loblaw, J. Trachtenberg, S.A. Narod, and A. Seth Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer Br J Cancer 97 2007 1690 1695
67. A.B. Rajput, M.A. Miller, A. De Luca, N. Boyd, S. Leung, A. Hurtado-Coll, L. Fazli, E.C. Jones, J.B. Palmer, M.E. Gleave, M.E. Cox, and D.G. Huntsman Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers J Clin Pathol 60 2007 1238 1243
68. G. Attard, J. Clark, L. Ambroisine, G. Fisher, G. Kovacs, P. Flohr, D. Berney, C.S. Foster, A. Fletcher, W.L. Gerald, H. Moller, V. Reuter, J.S. De Bono, P. Scardino, J. Cuzick, C.S. Cooper Transatlantic Prostate Group Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer Oncogene 27 2008 253 263
69. M. Yoshimoto, A.M. Joshua, I.W. Cunha, R.A. Coudry, F.P. Fonseca, O. Ludkovski, M. Zielenska, F.A. Soares, and J.A. Squire Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome Mod Pathol 21 2008 1451 1460
70. R. Singareddy, L. Semaan, M.K. Conley-Lacomb, J. St John, K. Powell, M. Iyer, D. Smith, L.K. Heilbrun, D. Shi, W. Sakr, M.L. Cher, and S.R. Chinni Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions Mol Cancer Res 11 2013 1349 1361
71. L. Wu, J.C. Zhao, J. Kim, H.J. Jin, C.Y. Wang, and J. Yu ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer Cancer Res 73 2013 6068 6079
72. T.V. Tian, N. Tomavo, L. Huot, A. Flourens, E. Bonnelye, S. Flajollet, D. Hot, X. Leroy, Y. de Launoit, and M. Duterque-Coquillaud Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2 Oncogene 33 2014 2204 2214
73. D. Pflueger, S. Terry, A. Sboner, L. Habegger, R. Esgueva, P.C. Lin, M.A. Svensson, N. Kitabayashi, B.J. Moss, T.Y. MacDonald, X. Cao, T. Barrette, A.K. Tewari, M.S. Chee, A.M. Chinnaiyan, D.S. Rickman, F. Demichelis, M.B. Gerstein, and M.A. Rubin Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing Genome Res 21 2011 56 67
74. K.W. Moremen, and P.W. Robbins Isolation, characterization, and expression of cDNAs encoding murine alpha-mannosidase II, a Golgi enzyme that controls conversion of high mannose to complex N-glycans J Cell Biol 115 1991 1521 1534
75. Q.L. Hao, N. Heisterkamp, and J. Groffen Isolation and sequence analysis of a novel human tyrosine kinase gene Mol Cell Biol 9 1989 1587 1593
76. J. Rocha, F.Z. Zouanat, A. Zoubeidi, L. Hamel, T. Benidir, E. Scarlata, F. Brimo, A. Aprikian, and S. Chevalier The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer Mol Cell Endocrinol 381 2013 140 149
77. C. Guo, and G.R. Stark FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB Proc Natl Acad Sci U S A 108 2011 7968 7973
78. E. Voisset, S. Lopez, P. Dubreuil, and P. De Sepulveda The tyrosine kinase FES is an essential effector of KITD816V proliferation signal Blood 110 2007 2593 2599
79. I.A. Ivanova, J.F. Vermeulen, C. Ercan, J.M. Houthuijzen, F.A. Saig, E.J. Vlug, E. van der Wall, P.J. van Diest, M. Vooijs, and P.W. Derksen FER kinase promotes breast cancer metastasis by regulating alpha6- and beta1-integrin-dependent cell adhesion and anoikis resistance Oncogene 32 2013 5582 5592
80. Y. Miyata, S. Kanda, H. Sakai, and P.A. Greer Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma Cancer Sci 104 2013 681 686
81. J. Ahn, P. Truesdell, J. Meens, C. Kadish, X. Yang, A.H. Boag, and A.W. Craig Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis Mol Cancer Res 11 2013 952 963
82. H. Li, Z. Ren, X. Kang, L. Zhang, X. Li, Y. Wang, T. Xue, Y. Shen, and Y. Liu Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells BMC Cancer 9 2009 366
83. J.J. Krolewski, R. Lee, R. Eddy, T.B. Shows, and R. Dalla-Favera Identification and chromosomal mapping of new human tyrosine kinase genes Oncogene 5 1990 277 282
84. J. Luo, S. Zha, W.R. Gage, T.A. Dunn, J.L. Hicks, C.J. Bennett, C.M. Ewing, E.A. Platz, S. Ferdinandusse, R.J. Wanders, J.M. Trent, W.B. Isaacs, and A.M. De Marzo Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer Cancer Res 62 2002 2220 2226
85. Y.E. Lee, H.L. He, S.W. Lee, T.J. Chen, K.Y. Chang, C.H. Hsing, and C.F. Li AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma Tumour Biol 35 2014 7983 7991
86. M.S. Tretiakova, S. Sahoo, M. Takahashi, M. Turkyilmaz, N.J. Vogelzang, F. Lin, T. Krausz, B.T. Teh, and X.J. Yang Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma Am J Surg Pathol 28 2004 69 76
87. G. Fellegara, S. Gabba, T. Dorji, G. De Luca, and M. Colecchia Observations on Aron et al's "Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3 CK20/CD44s/p53) and alpha-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia" Am J Surg Pathol 38 2014 1013 1015
88. K. Shilo, T. Dracheva, H. Mani, J. Fukuoka, I.A. Sesterhenn, W.S. Chu, J.H. Shih, J. Jen, W.D. Travis, and T.J. Franks Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis Arch Pathol Lab Med 131 2007 1555 1560
89. S. Scheil-Bertram, D. Lorenz, C. Ell, E. Sheremet, and A. Fisseler-Eckhoff Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus Mod Pathol 21 2008 961 967
90. W. Huang, J. Zhao, L. Li, Y. Huang, X. Yang, J. Wang, and T. Zhang a-Methylacyl coenzyme A racemase is highly expressed in the intestinal-type adenocarcinoma and high-grade dysplasia lesions of the stomach Histol Histopathol 23 2008 1315 1320
91. W. Li, P.T. Cagle, R.C. Botero, J.J. Liang, Z. Zhang, and D. Tan Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma J Exp Clin Cancer Res 27 2008 2
92. Y.S. Ha, Y.W. Kim, B.D. Min, O.J. Lee, Y.J. Kim, S.J. Yun, S.C. Lee, and W.J. Kim Alpha-methylacyl-coenzyme a racemase-expressing urachal adenocarcinoma of the abdominal wall Korean J Urol 51 2010 498 500
93. Z. Jiang, G.R. Fanger, B.F. Banner, B.A. Woda, P. Algate, K. Dresser, J. Xu, S.G. Reed, K.L. Rock, and P.G. Chu A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma Cancer Detect Prev 27 2003 422 426
94. S. Zha, S. Ferdinandusse, S. Denis, R.J. Wanders, C.M. Ewing, J. Luo, A.M. De Marzo, and W.B. Isaacs Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer Cancer Res 63 2003 7365 7376
95. R.P. Fisher, and D.O. Morgan A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase Cell 78 1994 713 724
96. R. Shiekhattar, F. Mermelstein, R.P. Fisher, R. Drapkin, B. Dynlacht, H.C. Wessling, D.O. Morgan, and D. Reinberg Cdk-activating kinase complex is a component of human transcription factor TFIIH Nature 374 1995 283 287
97. T.P. Makela, J.D. Parvin, J. Kim, L.J. Huber, P.A. Sharp, and R.A. Weinberg A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription Proc Natl Acad Sci U S A 92 1995 5174 5178
98. K. Jividen, and H. Li Chimeric RNAs generated by intergenic splicing in normal and cancer cells Genes Chromosomes Cancer 53 2014 963 971
99. M. Gajecka, C.D. Glotzbach, M. Jarmuz, B.C. Ballif, and L.G. Shaffer Identification of cryptic imbalance in phenotypically normal and abnormal translocation carriers Eur J Hum Genet 14 2006 1255 1262
100. S. Velaeti, E. Dimitriadis, K. Kontogianni-Katsarou, A. Savvani, E. Sdrolia, G. Pantazi, S. Stefanakis, T. Trangas, N. Pandis, and K. Petraki Detection of TMPRSS2-ERG fusion gene in benign prostatic hyperplasia Tumour Biol 35 2014 9597 9602